Dentsply Sirona (XRAY) Tops Q2 EPS by 2c, provides guidance
Tweet
Share
E-mailGet Alerts XRAY Hot Sheet
Price: $11.00 -3.34%
EPS Growth %: -36.0%
Financial Fact:
Cost of products sold: 440.6M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -36.0%
Financial Fact:
Cost of products sold: 440.6M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Dentsply Sirona (NASDAQ: XRAY) reported Q2 EPS of $0.52, $0.02 better than the analyst estimate of $0.50. Revenue for the quarter came in at $936 million versus the consensus estimate of $933.63 million.
GUIDANCE:
Dentsply Sirona sees FY2025 EPS of $1.80-$2.00, versus the consensus of $1.88. Dentsply Sirona sees FY2025 revenue of $3.6-3.7 billion, versus the consensus of $3.65 billion.
For earnings history and earnings-related data on Dentsply Sirona (XRAY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Braze, Inc. (BRZE) Tops Q2 EPS by 4c; offers guidance
- Piper Sandler Starts Oklo (OKLO) at Overweight
- StoneX Starts Magna Int'l (MGA) at Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
